The amplification of Shh signalling and the resorption of primary cilia are characteristic of both HDAC6 activity [73,270,271] and GSCs, further strengthening the importance of GSCs targeting to the treatment of GBM. This evidence concerns the gene HDAC6 and glioblastoma.